Nsg 533 exam 2 - Study guides, Class notes & Summaries

Exam 1: NSG533 / NSG 533 (Latest 2024 / 2025 Update) Advanced Pharmacology Exam| Questions and Verified Answers with Rationales | 100% Correct | Grade A - Wilkes Q: In order to determine how much T4 replacement a patient needs to re-establish a euthyroid state, the NP considers: 1. the TSH value 2. the patient's T4 3. the patient's body weight 4. the patient's gender Answer: 3. the patient's body weight Replacement is based on body weight and is usually calculated in kg. The patients weight is c...

Exam 2: NSG533 / NSG 533 (Latest 2024 / 2025 Update) Advanced Pharmacology Exam Review | Complete Guide with Questions and Verified Answers | 100% Correct - Wilkes Q: How does Tramadol work? Answer: It is a centrally acting synthetic opioid with weak SSRI/SNRI activity. Q: What are the daily dose limits for Tramadol? Answer: Maximum of 200mg per day. Q: What are the potential interactions of Tramadol? Answer: Increased risk of seizures with TCAs and other SSRIs, risk for serotonin syndrome. Q: W...

NSG 533 | NSG533 Exam 2 Questions and Answers Graded A+ | Latest 2024 | Wilkes NSG 533 | NSG533 Exam 2 Questions and Answers Graded A+ | Latest 2024 | Wilkes

Exam 2: NSG533 / NSG 533 (Latest 2024 / 2025) Advanced Pharmacology Review | Questions and Verified Answers | 100% Correct | Grade A - Wilkes Q: NSAID use Nonselective COX-1 and COX-2 inhibitors (COX-2 does anti-inflammation) Precaution: GI issues, renal toxicity, antiplatelet effect No NSAID is better than others- but vary from patient to patient Best for: RA, menstrual cramps, postsurgical pain, bony metastasis Flat-dose curve response: higher doses aren't more effective than moderate doses b...

NSG 533 (NSG533) Exam 2 | Advanced Pharmacology Exam 2 | Latest 2024 NSG 533 (NSG533) Exam 2 | Advanced Pharmacology Exam 2 | Latest 2024 NSG 533 (NSG533) Exam 2 | Advanced Pharmacology Exam 2 | Latest 2024

NSG 533 Exam 2 | Advanced Pharmacology Exam 2 | Answered and Rated A+ | Wilkes NSG 533 Exam 2 | Advanced Pharmacology Exam 2 | Answered and Rated A+ | Wilkes

NSG 533 (NSG533) Advanced Pharmacology Exam 2 | Questions and Answers Graded A+ | Latest 2024 NSG 533 (NSG533) Advanced Pharmacology Exam 2 | Questions and Answers Graded A+ | Latest 2024 NSG 533 (NSG533) Advanced Pharmacology Exam 2 | Questions and Answers Graded A+ | Latest 2024

NSG 533 ADVANCED PHARMACOLOGY EXAM 2 /NSG 533 Advanced Pharmacology Exam 2(Module 5 PAIN and Headaches) ACTUAL EXAM 100 QUESTION AND CORRECT DETAILED ANSWERS WITH RATIONALES RATED AGRADE.

Exam 2: NSG533 / NSG 533 (Latest 2024 / 2025 Update) Advanced Pharmacology Exam | Questions and Verified Answers | 100% Correct | Grade A - Wilkes Q: When are ACEIs or ARBs added in treatment of CS/carotid artery disease? Answer: When thiazide diuretics and CCBs fail to achieve treatment goals. Q: When do you start anti-platelet therapy in patients with CS/carotid artery disease? Answer: Symptomatic for 21 days or more Q: What medication and dose are preferred anti-platelet's for CS/carotid art...

Exam 3: NSG533 / NSG 533 (Latest 2024 / 2024 Update) Advanced Pharmacology Exam Review | Guide with Questions and Verified Answers | 100% Correct - Wilkes Q: Short-acting muscarinic antagonist (SAMA) Answer: Ipratropium Q: avoid co administration of ICS with which CYP3A4 inhibitors? (may cause cushing's) Answer: ritonavir, itraconazole, ketoconazole Q: lack of response to ICS may be indicative of what? Answer: CLCCl1 gene Q: LABAs Answer: Salmeterol Formoterol Vilanterol Q: LAMAs Answer: tiotro...